AMSTERDAM (Reuters) - Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.61 billion) in cash and reinvest in chemicals and plastics.
Reuters: Business News, Reuters: Business
Sun, 09/27/2009 - 10:30pm
AMSTERDAM (Reuters) - Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.61 billion) in cash and reinvest in chemicals and plastics.